Next 10 |
home / stock / hbi / hbi articles
Crocs Inc. (NASDAQ: CROX) is well-placed for long-term growth, backed by its business strategy and key initiatives, which are expected to deliver s...
The year 2023 was impressive for Wall Street. Heading into 2024, some bottlenecks, including geopolitical upheavals and stretched valuations, raise...
Carter's, Inc. (NYSE: CRI) has been capitalizing on its pricing strategy, efficient inventory management and enhanced product offerings. It has...
Hanesbrands Inc. (NYSE:HBI) shares are trading higher after the company inked a deal to sell its Champion business to Authentic Brands Group f...
Hanesbrands Inc. (NYSE:HBI) shares are trading higher on Thursday. The company reported a first-quarter adjusted loss per share of two ce...
Trading in U.S. index futures suggests stocks may be off to a lackluster start again on Thursday. Much of the negativity in the recent session was ...
Earnings reports and a dovish stance from the Federal Reserve lifted stocks last week. Major indices reacted positively, particularly to ...
Shares of Herbalife Ltd. (NYSE: HLF) fell sharply in today’s session following weak quarterly earnings. Herbalife posted adjusted earnings o...
HanesBrands Inc (NYSE:HBI) shares are trading lower after the company reported fourth-quarter FY23 results. Sales declined 12% Y/Y to $1....
News, Short Squeeze, Breakout and More Instantly...
A partnership between HanesBrands and Foundation Educating a Salvadoran (FESA) has benefited more than 2,500 students through two soccer academies near its facilities in San Juan Opico and Santiago Nonualco, El Salvador. NORTHAMPTON, MA / ACCESSWIRE / June 28, 2024 / HanesBrands Originally ...
HOLLISTON, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be presenting to investors at the 14 th Annual East Coast IDEAS Conference at the ...
2024-06-05 19:15:02 ET UBS analyst issues NEUTRAL recommendation for HBI on June 5, 2024 05:20PM ET. The previous analyst recommendation was Neutral. HBI was trading at $5.3 at issue of the analyst recommendation. The overall analyst consensus : HOLD. Current analyst...